PHARMACOIMMUNODYNAMICS OF METHYLPREDNISOLONE - TRAFFICKING OF HELPER LYMPHOCYTES-T

被引:43
作者
FISHER, LE
LUDWIG, EA
JUSKO, WJ
机构
[1] SUNY BUFFALO,SCH PHARM,DEPT PHARMACEUT,HOCHSTETTER 565,BUFFALO,NY 14260
[2] SUNY BUFFALO,SCH PHARM,DEPT PHARM,BUFFALO,NY 14260
[3] BUFFALO GEN HOSP,DEPT PHARM,BUFFALO,NY 14203
来源
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 1992年 / 20卷 / 04期
关键词
METHYLPREDNISOLONE; HELPER LYMPHOCYTES-T; PHARMACODYNAMICS; CELL TRAFFICKING; CHRONOPHARMACOLOGY; IMMUNOSUPPRESSION;
D O I
10.1007/BF01062461
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A two-compartment closed model was used to characterize the cell trafficking behavior of helper T cells in response to various single doses of methylprednisolone. Steroids are assumed to inhibit the circadian-determined cell return from extravascular sites to blood in a classic inhibitory pattern reflected by an IC50. The rate of cell efflux from tissues is modeled with a cosine function having a period of 24 hr and a maximum at about 1 AM. Nonlinear least-squares regression employing differential equations was used to analyze helper T-cell data from three human studies from our laboratory. The IC50 value of methylprednisolone of 12-19 ng/ml approximates receptor K(D) values. Simulations were performed to demonstrate the log-linear role of steroid dose or AUC on the integral of effect of helper T cells over a wide range of methylprednisolone doses. This pharmacodynamic model allows flexibility for characterizing any type of steroid dosing regimen and is relevent in describing complex response data for corticosteroid immunosuppressive effects in man.
引用
收藏
页码:319 / 331
页数:13
相关论文
共 20 条
[1]  
ABO T, 1981, J IMMUNOL, V126, P1360
[2]   DIURNAL-VARIATION OF LYMPHOCYTE SUBSETS IDENTIFIED BY MONOCLONAL-ANTIBODIES [J].
BERTOUCH, JV ;
ROBERTSTHOMSON, PJ ;
BRADLEY, J .
BRITISH MEDICAL JOURNAL, 1983, 286 (6372) :1171-1172
[3]   THE MIGRATION OF LYMPHOCYTES ACROSS SPECIALIZED VASCULAR ENDOTHELIUM .4. PREDNISOLONE ACTS AT SEVERAL POINTS ON THE RE-CIRCULATION PATHWAYS OF LYMPHOCYTES [J].
COX, JH ;
FORD, WL .
CELLULAR IMMUNOLOGY, 1982, 66 (02) :407-422
[4]   PHARMACOKINETICS AND PHARMACODYNAMICS OF METHYLPREDNISOLONE IN OBESITY [J].
DUNN, TE ;
LUDWIG, EA ;
SLAUGHTER, RL ;
CAMARA, DS ;
JUSKO, WJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (05) :536-549
[5]   THE EFFECTS OF TRIACETYLOLEANDOMYCIN AND OLEANDOMYCIN PHOSPHATE ON THE GLUCOCORTICOID RECEPTOR IN CULTURED SKIN FIBROBLASTS [J].
ENGLER, RJM ;
CHESTNUT, RY ;
BORST, GC ;
EIL, C .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1985, 75 (03) :395-400
[6]  
FAN PT, 1978, J LAB CLIN MED, V91, P625
[7]  
FAUCI AS, 1975, BLOOD, V46, P235
[8]  
FAUCI AS, 1975, IMMUNOLOGY, V28, P669
[9]   PHARMACOKINETICS AND PHARMACODYNAMICS OF METHYLPREDNISOLONE WHEN ADMINISTERED AT 8 AM VERSUS 4 PM [J].
FISHER, LE ;
LUDWIG, EA ;
WALD, JA ;
SLOAN, RR ;
MIDDLETON, E ;
JUSKO, WJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (06) :677-688
[10]   CHRONOBIOLOGY IN HEMATOLOGY AND IMMUNOLOGY [J].
HAUS, E ;
LAKATUA, DJ ;
SWOYER, J ;
SACKETTLUNDEEN, L .
AMERICAN JOURNAL OF ANATOMY, 1983, 168 (04) :467-517